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Abstract
Background: Aiming to understand cellular responses to different perturbations, the NIH Common Fund Library of
Integrated Network-based Cellular Signatures (LINCS) program involves many institutes and laboratories working on
over a thousand cell lines. The community-based Cell Line Ontology (CLO) is selected as the default ontology for
LINCS cell line representation and integration.
Results: CLO has consistently represented all 1097 LINCS cell lines and included information extracted from the
LINCS Data Portal and ChEMBL. Using MCF 10A cell line cells as an example, we demonstrated how to ontologically
model LINCS cellular signatures such as their non-tumorigenic epithelial cell type, three-dimensional growth,
latrunculin-A-induced actin depolymerization and apoptosis, and cell line transfection. A CLO subset view of LINCS
cell lines, named LINCS-CLOview, was generated to support systematic LINCS cell line analysis and queries. In
summary, LINCS cell lines are currently associated with 43 cell types, 131 tissues and organs, and 121 cancer types.
The LINCS-CLO view information can be queried using SPARQL scripts.
Conclusions: CLO was used to support ontological representation, integration, and analysis of over a thousand
LINCS cell line cells and their cellular responses.
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Background
Since immortalized cell lines were developed almost one
century ago, various cell lines have been widely used to
study various scientific biological and biomedical questions
[1]. The NIH Common Fund Library of Integrated
Network-based Cellular Signatures (LINCS) program [2]
aims to create a network-based biological understanding of
gene expression profiles and cellular processes when cells,
mostly cell line cells, are exposed to various experimental
conditions and perturbing agents (http://www.lincsprojec-
t.org/). Diverse, multi-dimensional datasets have been
generated by LINCS groups and laboratories and used to
generate extensive results and software programs. A major
challenge is how to integrate large amounts of
LINCS-generated data into a comprehensive integrative
understanding of cellular signatures [3]. Given that cell
line cells play a critical role in LINCS studies, it is possible
to use cell line cells as a hub pointing to semantics link
and integrate various molecular and cellular signatures
and networks to address various biomedical questions.
Co-developed by many groups and societies, including
the Cell Type Ontology (CL) [3], Ontology for Biomedical
Investigations (OBI) [4], BioAssay Ontology (BAO) [5],
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Drug Target Ontology (DTO) [6], Vaccine Ontology (VO)
[6, 7], the European Bioinformatics Institute (EBI), and the
Japan Riken BioResource Center, the community-based Cell
Line Ontology (CLO) [8] aims to comprehensively repre-
sent cell line cells, cell lines, and their related entities such
as corresponding cell types, tissues, organs, organisms, and
possible diseases. CLO is developed by following the princi-
ples of the Open Biological and Biomedical Ontologies
(OBO) Foundry [9]. Currently, CLO represents nearly 40,000
cell lines from various resources such as the American
Type Culture Collection (ATCC) (http://www.atcc.org/),
HyperCLDB [10], Coriell Cell lines (https://catalog.coriel-
l.org/), and Japan Riken cell lines (http://cell.brc.riken.jp/
en/). CLO has been used in many projects such as BAO
development [5], Beta cell genomes [11], Chromosome-
Centric Human Proteome Project [12], ChEMBL database
[13], and Cellosaurus (http://web.expasy.org/cellosaurus/).
Among these resources, the ChEMBL database, a large-
scale bioactivity database developed by the EBI [13, 14], is
for drug-like compounds and contains many cell lines and
their cross-references in different resources including CLO
and LINCS.
In this study, we report our work on updating CLO to
include all LINCS cell lines and additional information
required by LINCS projects. Such a comprehensive and
integrative representation makes CLO able to coherently
represent and study all LINCS cell lines together. To
support LINCS integrated study of cellular features and
signatures, we have also updated CLO to include add-
itional design patterns using the cell line model MCF
10A cell line cells.
Methods
The overall workflow of this project (Fig. 1) includes and
integrates different methods of this study. Specific
methods of this pipeline are described below.
CLO modeling of LINCS cell line information and design
pattern generation
Based on the data types obtained from the mapping process,
an updated CLO design pattern model was generated in
order to accommodate new LINCS cell line data attributes.
Information extraction of LINCS cell lines
Two sources, including the LINCS Data Portal (http://
lincsportal.ccs.miami.edu/) [14] and ChEMBL, were used
to obtain LINCS cell line information. The information
of the cell lines available from the LINCS Data Portal
was directly downloaded from its website. In our study,
the ChEMBL data (release 21) was downloaded into a
local MySQL database. LINCS cell lines available in the
database were identified using LINCS_ID, and related
data were then extracted from ChEMBL.
Cell line data mapping and comparison between
resources
Cell line-related data types or attributes were first com-
pared between LINCS Data Portal and ChEMBL and then
compared with the CLO knowledge base. To identify if a
LINCS cell line found from the LINCS Data Portal and
ChEMBL also exists in CLO, SPARQL scripts [15] were
generated to map the labels of LINCS cell lines with CLO
cell line labels or alternative names (i.e., cell line synonyms)
using string-based name matching.
The mapped cell line data from CLO was also used to
support LINCS cell line data integration. Following
SPARQL-based identification of cell line names and
Fig. 1 Project pipeline of integrating cell lines from LINCS data
portal and ChEMBL into CLO
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synonyms within CLO, along with the corresponding
Disease Ontology Identifiers (DOIDs), information for
the LINCS cell lines was manually validated and curated
to ensure accurate information matches. If existed,
multiple members of the same cell line name or synonym
were consolidated into a singular LINCS cell identifier.
New information incorporation into CLO
Based on the new design patterns, Ontorat [16] was used
to incorporate LINCS cell line data from different data
sources to CLO. Two steps were performed. The first
step was to add to existing CLO cell lines with new data
obtained from LINCS and ChEMBL, and the second
step was to add new LINCS cell lines to CLO. Manual
checking was performed to ensure correctness.
Generation of a LINCS cell line set of CLO
OntoFox [17] was used to generate a CLO subset (named
as LINCS-CLOview) that includes all LINCS cell lines and
related ontology terms and relations. The source code of
the LINCS-CLOview was submitted to the CLO GitHub
website with the following web page URL: https://raw.-
githubusercontent.com/CLO-ontology/CLO/master/src/
ontology/LINCS-CLOview.owl. The LINCS CLO subset
was also submitted to Ontobee [18]. The information of
the subset can be queried using the Ontobee SPARQL web
program (http://www.ontobee.org/sparql).
CLO-based analysis of LINCS cell lines
Note that CLO and LINCS-CLOview are developed using
the Web Ontology Language (OWL) [19] and contain rich
axiomatizations. Using the many axioms generated in the
ontologies, the OWL reasoning can be used to support
the inference of classification and direct information quer-
ies in the ontology. In addition, the construction of the
classification hierarchy based on OWL reasoning can also
be used to support enriched SPARQL queries [15] over
the ontology information stored in an RDF triple store.
Based on the OWL-based classification and reasoning
features, the CLO subset of LINCS cell lines was used for
further analysis. The subset statistics was first generated
and analyzed. Different types of LICNS cell line informa-
tion were queried and studied. For example, the cell types
of LINCS cell lines were studied based on the Cell Type
Ontology (CL) [3], and the diseases modeled by the
LINCS cell lines were studied based on the Disease
Ontology [20] hierarchical structure information.
Results
LINCS cell line information extraction and mapping from
different resources
As of June 15, 2017, 1097 cell lines were extracted from
the LINCS Data Portal. Out of these LINCS cell lines,
794 cell lines could be directly mapped to CLO based on
exact name matching and manual verification. A cell line
may have different synonyms. The name matching used
the default label and different synonyms for lexical map-
ping between these two resources. The data types related
to these cell lines are listed in Fig. 2a. Meanwhile, the
ChEMBL database included 637 cell line entries that
have LINCS IDs. Out of these cell lines, 451 cell lines
also have CLO_IDs, and 51 out of the remaining 186 cell
lines could be mapped to CLO using name matching.
The data types available related to these cell lines in
ChEMBL are shown in Fig. 2b.
Among the 1097 LINCS cell lines each with a unique
LINCS cell line ID (e.g., LCL-1512 for HeLa cell), 466
had ChEMBL, LINCS, and CLO IDs, 279 had both
LINCS and CLO IDs, and 352 LINCS cell lines did not
have any CLO IDs.
Note that sometimes one LINCS ID maps to multiple
CLO IDs. For example, the Hep G2 cell line (http://
www.atcc.org/products/all/HB-8065.aspx) has the
LINCS ID LCL-1925, and it is mapped to three CLO
IDs: CLO_0003704 (term label: Hep G2 cell),
CLO_0050856 (label: RCB1648 cell), and CLO_0050858
(RCB1886 cell). Although they are all for Hep G2 cell
based on their annotations,CLO_0003704 was the ori-
ginally assigned based on an annotation from the ATCC
cell line repository, and the other two come from the
Japan RIKEN cell line bank with different registry infor-
mation. In current CLO, we assert the two Japan cell
bank cell line cell terms as subclasses of the
CLO_0003704 with the consideration that the two Japan
cell bank cell line cell types may have genetic variations
given their long time of passages. In this case, all the
three CLO cell line cell terms have the same LINCS cell
line ID, which is defined using an annotation property
‘Cell line LINCS ID’.
Fig. 2 Cell line-related data types of the data downloaded from LINCS
Data Portal and ChEMBL. a Data types from LINCS Data Portal. b Data
types from ChEMBL. Red-highlighted items (e.g., ChEMBL ID) were not
covered in CLO, which were added later to CLO in this study
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CLO modeling and design pattern generation
In CLO, the basic unit for representing a cell line is the
term ‘cell line cell’, which is defined as “a cultured cell that
is part of a cell line - a stable and homogeneous population
of cells with a common biological origin and propagation
history in culture” [8]. As shown in Fig. 1, the new cell line
information identified from the LINCS project and
ChEMBL database is of different types of names/descrip-
tion and data resource IDs. Such information can be effect-
ively represented as specific annotation types. The strategy
is reflected in a simple CLO design pattern model (Fig. 3),
which was generated based on the general CLO design pat-
tern reported in the original CLO paper [8].
For example, for the HeLa cell (CLO_0003684), based on
the updated design pattern, we added the following infor-
mation to CLO: ‘Cell line LINCS ID: LCL-1512’ and
‘seeAlso: EFO: EFO_0001185; CHEMBL: CHEMBL3308376;
CVCL: CVCL_0030’.
Most LINCS cell lines were originally derived from
human patients with some specific cancer diseases, and
many of these diseases were not included in CLO. In
this study, we imported corresponding disease terms
from the Human Disease Ontology (DOID) [20]. To rep-
resent the relation between a cell line cell and a disease,
we generated a new object property called ‘is disease
model for’ (CLO_0000179). For example, for the HeLa
cell, an OWL SubClassOf axiom was generated to repre-
sent its usage in studying cervical adenocarcinoma:
‘HeLa cell’ (CLO_0003684): ‘is disease model for’ some
‘cervical adenocarcinoma’
It is noted that in CLO, the new object property ‘is dis-
ease model for’ is equivalent to the original object prop-
erty ‘is model for’, an object property originated by the EBI
cell line project (http://www.ebi.ac.uk/cellline#is_model_-
for) [8]. The EBI cell line project relation is obsolete. Re-
placing the obsolete legacy object property ‘is model for’
with the new CLO relation supports the ontology
updating and standardization.
The direct link between a disease and a cell line as a
model to study the disease is required by LINCS data
structure. In addition to this direct link, CLO also pre-
sents the origination of a cell line from a formalized
ontological representation. The disease that is modeled
by a cell line is often the disease of the particular human
patient from whom the first passage of the cell line was
originally generated. For example, the HeLa cell’s origin
was the cervical adenocarcinoma cells separated from a
cervical cancer patient, an African American woman in
1951 [21]. To represent the relation between the disease
and the patient (original source for the cell line), the
Fig. 4 design pattern was applied. For example, the fol-
lowing OWL SubClassOf axiom represents a human-cell
relation for the HeLa cell in CLO:
‘HeLa cell’: ‘derives from’ some (‘epithelial cell’ and
(part_of some (‘uterine cervix’ and (part_of some
(‘Homo sapiens’ and (‘has disease’ some ‘cervical
adenocarcinoma’)))))
It is noted that HeLa cell is listed in CLO as a subclass
of ‘immortal human uterine cervix-derived epithelial cell
line cell’ (CLO_0000636), where the relation between
human and the cell is clearly stated.
It is also noted from the above axiom that the long chain
of axiom (i.e., cell line cell – cell type – tissue – organ – or-
ganism – disease) shown above becomes technically ineffi-
cient to query the relation between the cell line cell and the
disease ‘cervical adenocarcinoma’. A shortcut relation (or
object property) is a relation that is used to replace the
usage of a chain of multiple relations and classes to repre-
sent the complex relations between two classes. Therefore,
a new shortcut relation (or called object property) ‘derives
originally from patient having disease’ (Fig. 4) was gener-
ated to directly link the cell line cell and disease as shown
in the following OWL SubClassOf axiom:
‘HeLa cell’: ‘derives originally from patient having
disease’ some ‘cervical adenocarcinoma’
Fig. 3 Basic CLO design pattern model for integrating LINCS cell line information from LINCS and ChEMBL
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Although ‘is disease model for’ and ‘derives originally
from patient having disease’ both represent a relation
between a cell line cell and a disease, these two relations
differ in their meaning. The shortcut relation ‘derives
originally from patient having disease’ represents that
the cell line cell was originally derived from a patient
with a specific disease. The relation ‘is disease model for’
indicates that the cell line can be used to study a specific
disease, and the disease can but does not have to, be the
same as the disease of the patient from whom the cell
line cell was derived. For example, HeLa cell can be used
as a cell line model to study cervical adenocarcinoma,
but it can also be used to study many other diseases
such as polio and NewCastle Disease [21, 22].
CLO modeling of cell features under regular cell culture
conditions
In this study, we used the MCF 10A cell line cell as
an example to show how CLO can be used to model
cell features.
MCF 10A cell line cell is non-tumorigenic [23]. CLO
represents such knowledge using the following OWL
SubClassOf axiom:
‘MCF 10A’: has_qality some non-tumorigenic
where the non-tumorigenic is represented as a quality,
and the relation between MCF 10A cell line cell and
the quality can be represented using the object
property has_quality.
MCF 10A cell line cells exhibit three dimensional
growth in collagen and form domes in confluent
cultures [23]. We can use the following OWL
SubClassOf axiom to represent such knowledge:
‘MCF 10A’: ‘participates in’ some (‘three dimensional
cell growth’ and (‘has participant’ some collagen)
In this case, ‘three dimensional cell growth’
(CLO_0037311) is a process, and both MCF 10A cell
line cell and collagen are participants of such a process.
Since GO does not have such a ‘three dimensional cell
growth’ term, we generated the term using a tentative
CLO ID (CLO_0037311) and listed it as a subclass of
the ‘cell growth’. Here the collagen is a component
needed for the three dimensional cell growth. Collagen
(CHEBI_3815) is a group of fibrous proteins of very high
tensile strength that form the main component of
connective tissue in animals.
CLO modeling of cellular responses to special agent
treatments
How to represent a cellular response of a cell line cell to
a specific agent that is not part of regular cell culture
media? Here we again use MCF 10A cell line cell
response modeling as an example study.
It is known that MCF 10A mammary epithelial cells
undergo apoptosis following actin depolymerization. The
Fig. 4 CLO design pattern model for using the new shortcut relation ‘derives originally from patient having disease’. a General design pattern; b
an example to illustrate the design pattern. The shortcut relation makes it more efficient to represent the relation between a cell line cell and a
disease when the parent term of the cell line cell includes sufficient information about the cell type and tissue/organ. In this illustration, the
classes as shown in the dotted boxes are redundant and are not needed
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MCF 10A response can be represented in the following
OWL SubClassOf axiom:
‘MCF 10A’: ‘participates in’ some (‘apoptotic process’
and ‘preceded by’ some ‘actin depolymerization’ and
(‘induced by cell culture reagent’ some latrunculin-A))
In this case, apoptotic process is represented as a GO
term (GO_0006915). This process in MCF10A cells
occurs after actin depolymerization (GO_0030042) is
induced by a cell culture reagent Latrunculin A
(CHEBI_69136), a bicyclic macrolide natural product
consisting of a 16-membered bicyclic lactone attached to
the rare 2-thiazolidinone moiety [24].
Sometimes, cell line cells were genetically engineered
to generate a new cell line by a transfection process.
Basically, a transfection process deliberately introduces
naked or purified nucleic acids into eukaryotic cells such
as cell line cells. For example, MCF10A-Er-Src cell line
cell is a MCF10A cell derived cell through transfection.
As a result, MCF10A-Er-Src cell has the part of ER-Src,
a derivative of the Src kinase onco-protein that is fused
to the ligand-binding domain of the estrogen receptor
(ER). It is clear that MCF10A-Er-Src cell line cell is not
a subtype of MCF 10A cell. The transfection process
makes the new cell a MCF 10A–derived cell type instead
of a subtype of MCF 10A per se. Specifically, CLO rep-
resents the new MCF10A-Er-Src cell line cell formation
as shown in the following OWL SubClassOf axiom:
‘MCF10A-Er-Src cell’: ‘is specified output of ’ some
(‘cell line cell transfection’ and (‘has specified input of ’
some ‘MCF 10A cell’))
LINCS-CLOview: LINCS cell line subset of CLO
Based on the mapping and the design pattern models
(Figs. 3 and 4), extra data available in the LINCS Data
Portal and ChEMBL were integrated into to CLO. To
improve the efficiency, a combination of manual annota-
tion/edition and Ontorat [16]-assisted automated process
was conducted.
The new information added to CLO includes two
parts:
(1)Existing 795 CLO cell line cell items were added
with newly obtained data (Fig. 2), e.g., LINCS cell
line IDs and disease information. All the disease
information was mapped to the Human Disease
Ontology (DOID) [20].
(2)352 LINCS cell lines unavailable in CLO were newly
added to CLO. Each of these cell lines was assigned
a new non-redundant CLO ID based on CLO cell
line naming convention [8]. The parent terms of
these newly added CLO cell lines were determined
by the cell type, tissue, organ, and organism. All the
cell lines were found to be derived from human. The
diseases in the human patients were primary
cancers. Three cell lines were derived from patients
with benign tumors.
LINCS-CLOview: LINCS cell line subset of CLO
A CLO subset of LINCS cell lines, abbreviated as LINCS-
CLOview, was generated. The LINCS-CLOview can be
considered as a “community view” [25] or a slim of the
CLO’s implementation of LINCS cell lines for the LINCS
research community. As of July 1, 2017, LINCS-CLOview
contained 1924 terms, including 1825 classes, 25 object
properties, 61 annotation properties, and 13 instances.
These terms include 1315 cell line cell terms with CLO
IDs. The other terms were imported from 17 other ontol-
ogies, for example, the Basic Formal Ontology (BFO) [26],
the Cell Type Ontology (CL) [3], and the Ontology for
Biomedical Investigations (OBI) [4]. The LINCS-CLOview
source code is included in the master CLO GitHub web-
site. The detailed statistics of LINCS-CLOview is available
at: http://www.ontobee.org/ontostat/LINCS-CLOview.
As a subset of CLO, LINCS-CLOview has the same
hierarchical structure and design patterns as the CLO.
BFO is the top-level ontology with which CLO is
aligned. Since BFO is also the top-level ontology for over
100 ontologies (e.g., CL and OBI), such an alignment
makes LINCS-CLOview easily integrated with other on-
tologies, such as CL for cell types, and OBI for cell line
related processes.
SPARQL query of LINCS-CLOview information
The Ontobee SPARQL web query program can be used
to conveniently query detailed information in LINCS-
CLOview. For example, Ontobee SPARQL was used to
query the number of cell line cells that have the LINCS
cell line IDs (i.e., LCL_xxxx) (Fig. 5). The script recur-
sively queries all class terms under the branch of ‘cell
line cell’ (CLO_0000001) in LINCS-CLOview, identifies
those terms having the ‘Cell line LINCS ID’
(CLO_0000178), and counts the total number of these
cell line cell terms. As shown in the figure, the total
unique number of these LINCS cell line cells with
LINCS cell line IDs in LINCS-CLOview (or CLO) is
1133. This number is greater than 1097 LINCS cell lines
extracted from our processes, which is because one
LINCS ID may sometimes be mapped to more than one
cell line in CLO as indicated at the beginning of the
Results section. If we do not consider the LINCS cell
line IDs, we would get 1541 cell line cell terms under
this cell line cell branch in the LINCS community view
of the CLO. The difference between these two numbers
reflects the fact that there are many intermediate-layer
cell line cell terms between the LINCS cell lines (with
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LINCS IDs) and the ‘cell line cell’ (CLO_0000001) in the
LINCS-CLOview.
In this study, different SPARQL scripts were developed
and used to analyze the LINCS cell lines from various
aspects. An example of such SPARQL analysis is illus-
trated in next section.
Analysis of LINCS cell lines by querying LINCS-CLOview
With the availability of LINCS-CLOview, we were able to
analyze LINCS cell lines from different aspects. The tools
used in our analyses include SPARQL-based queries,
Protégé OWL editor visualization, and Ontobee statistics
display and queries. Below we describe our analyzed
results from three main aspects: related diseases, cell
types, and tissues/organs.
Our study found that LINCS cell lines are associated
with 121 diseases. These 121 diseases include three benign
neoplasms, i.e., breast fibrocystic disease (associated with
MCF 10A and MCF 10F cells), kidney angiomyolipoma
(associated with 621–101 cell), and male productive organ
benign neoplasm (associated with BPH-1 cell). The other
118 diseases are various types of cancers. Fig. 6 is a
hierarchical DOID structure of organ system cancers
related to these LINCS cell lines.
The hierarchical structure of DOID (Fig. 6) helped the
understanding of all the diseases associated with LINCS
cell lines. For example, Fig. 6 demonstrates that 8 LINCS
cell lines (e.g., HeLa cell) were derived from patients
with cervical adenocarcinoma, 1 with cervical clear cell
adenocarcinoma (a specific type of cervical adenocarcin-
oma), and 6 with cervical squamous cell carcinoma.
These diseases all belong to cervix carcinoma. In
addition, ‘cervix carcinoma’ is directly associated with 2
LINCS cell lines (i.e., C-33 A and C-4 II cell line cells).
Therefore, if we plan to study the cellular signatures of
cervix carcinoma, we would focus on these 17 cell lines
instead of just 2 cell lines directly annotated as derived
from a patient having cervix carcinoma.
To further illustrate the usage of LINCS-CLOview, we
generated a SPARQL script that queries the cell lines ori-
ginally derived from human patients having more specific
disease names under cervix carcinoma (Fig. 7). Consistent
with Fig. 6, our query identified 15 new cell line cell types
(e.g., HeLa cell line cell) that belong to this category, and 5
identified cell line cell types are shown in Fig. 7.
We also examined the tissue and organ types from which
the LINCS cell lines were derived. In CLO, the multi-
species anatomy ontology UBERON [27] is used to repre-
sent tissues and organs. In total 131 UBERON terms have
been used in LINCS-CLOview to refer to various anatomic
locations from which LINCS cell lines were derived. A part
of the UBERON structure is illustrated in Fig. 8.
The cell types of LINCS cell lines were analyzed. The
Cell Type Ontology (CL) [3] was used in CLO to demon-
strate the cell types of different cell lines. In total, 43 CL
cell types, such as epithelial cell, B cell, and T cell, are
included in LINCS-CLOview. Each of these cell types is
linked to different cell line cells or the parent terms of cell
line cells. For a project to study cellular signatures related
to a specific cell type, the LINCS-CLOview provides a
feasible method to identify which cell line cells to use.
Discussion
The contributions of this study are multiple. First of all,
we systematically annotated the LINCS cell lines and
integrated the information of the cell lines from different
Fig. 5 SPARQL query of the number of cell lines with LINCS ID annotation. The query was performed using Ontobee
SPARQL (http://www.ontobee.org/sparql)
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resources to CLO. Second, two more object properties,
including ‘is disease model for’ and ‘derives originally
from patient with disease’, were newly generated in CLO
in order to use CLO to represent the information of
LINCS cell lines. Third, using MCF 10A, we show how
to use CLO to represent cell line cell features and a
cellular response to an extracellular agent. Fourth, we
generated the LINCS-CLOview, a CLO community view
for the LINCS research community, which will serve as
a CLO standardized module for LINCS data integration
and coordination. Fifth, useful information about the
LINCS cell lines was obtained via analyzing LINCS-
CLOview. Given well-defined class hierarchy and axiom
assertions and OWL reasoning, our analyses showed
that ontology SPARQL was also able to query results for
different use cases. This study is timely updating and
implementation of CLO for enhanced cell line data inte-
gration and analysis features.
We have for the first time showed in this study how to
use CLO to represent specific cellular responses to
agents such as collagen, Latrunculin A, or transfection
agents. Such treatments make the cells form 3D growth,
apoptosis, or a new cell line cell type. Each cellular
process is represented separately based on its own
characteristics. More specifically, for each process, we
typically use the pattern of ‘participates in’ some specific
process which is either a term obtained from an existing
ontology such as GO, or a term generated in CLO if
such a process term cannot be found from any existing
community-based ontology. After such modeling
discussed and agreed by the manuscript reviewers and
presentation audience, we plan to extend such design
patterns to represent cellular responses of other CLO
cell line cells.
To our knowledge, this article is the first report of
implementing CLO by developing a CLO community
view (or slim) to serve a specific community, in this
case, the LINCS research community. Since tens of
thousands of cell lines have been represented in CLO, it
is not efficient to use the whole CLO for LINCS cell line
related research. The generation of LINCS-CLOview in
this study allows the standardization and modularization
of the LINCS cell lines, which facilitates the better ana-
lysis and reuse of the LINCS cell line information. Such
a strategy can also be used to represent and study cell
lines used by other communities.
One advantage of this CLO-based LINCS cell line
representation is to bring together different cell line
resources (e.g., LINCS, ChEMBL, and Cellosaurus) with
the framework of CLO. Our integration of LINCS cell
lines and CLO ensures the consistency and integrity of
the cell line data across multiple resources. In many
cases, a key challenge of systematically studying diverse
systems biology signature data such as LINCS is the
difficulty in integration of different data types and infor-
mation related to various cell lines. LINCS-CLOview
provides a cell line-oriented semantic framework and
foundation for integrating different cell line study results
Fig. 6 The DOID hierarchy of 121 diseases of patients from whom 1133 LINCS cell lines were derived. The red color numbers represent the
number of LINCS cell lines that are associated with corresponding diseases
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and supporting systematical analysis of cellular
signatures and network studies.
Our future work will include different directions. One
major direction is to apply the ontological representation
of LINCS cell lines in LINCS-CLOview to systematically
study cellular molecular markers. For example, we can
study cellular markers based on different criteria such as
disease, cell type, tissue, and organ. As illustrated in
Figs. 6 and 7, if we want to study cervix carcinoma, we
can easily identify 17 related cell lines. The hierarchical
structures of different types of entities are useful since
you can often find more information. For example, based
on the Fig. 6 hierarchy, there are clearly more than 2 cell
lines that are related to cervix carcinoma. Another
possible future work is to apply LINCS-CLOview to
map cell lines to specific experimental LINCS datasets
or specific project(s) and identify scientific insights that
associate different types of cell line cells with experi-
mental conditions. We also plan to study cell line
cell-specific gene/protein interactions and pathways
and compare them based on different types of cell
line classifications.
Fig. 8 Part of the UBERON hierarchical structure in LINCS-CLOview.
This structure shows the location of ‘uterine cervix’. This is a screenshot
of the UBERON term in the LINCS-CLOview Ontobee web page
Fig. 7 Identification of additional cell lines under cervix carcinoma by SPARQL querying LINCS-CLOview. Note that DOID_2893 is the class ‘cervix
carcinoma’, and CLO_0000015 is the object property ‘derives originally from human having disease’. In total 15 cell line cells were identified. Here
only 6 are shown up. The query was conducted using Ontobee SPARQL (http://www.ontobee.org/sparql)
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As a community-based ontology, the CLO team is also
collaborating with other research projects that heavily use
cell lines, such as the European Bioinformatics Institute
(EBI) that uses many cell lines in their EBI projects. EBI
uses the Experimental Factor Ontology (EFO) to represent
various experimental factors such as cell line cells. We are
now teaming with EBI to synchronize the cell line cells in
EFO and CLO. We are also working with the China Cell
Line Bank group to add their cell lines and their specific
needs to CLO. Such activities will make CLO a more
community-based centralized ontology source for cell line
cell representation, supporting integrative cellular research
to solve different scientific questions.
Conclusions
In summary, we updated CLO by incorporating the
information of all identified LINCS cell lines and used
CLO to model cellular responses to different cell culture
growth conditions and perturbations. LINCS-CLOview,
a CLO subset of the LINCS cell line information, was
generated and analyzed to better understand LINCS cell
line information.
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